THYTECH is a spin-off of the Gregorio Marañón Health Research Institute (IISGM) that was created with the aim of transferring to the patient our patented technology for the treatment of diseases related to immune disorders.
The company arises from the work carried out by the researchers of the Immunoregulation Laboratory, and our main asset is a cellular therapy with thyTreg cells that is pioneering in the world that can establish a new paradigm in the prevention of transplant rejection and in the treatment of autoimmune diseases and clinical worsening of COVID patients.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Madrid, Es
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.thytech.com
- HQ
- Madrid
Thytech Questions
Thytech's website is http://www.thytech.com
Thytech's LinkedIn profile is https://es.linkedin.com/company/thytech
Thytech has
6 employees.
View email and phone details for 6
employees at Thytech.
Thytech's industry is
Biotechnology Research
Thytech's top competitors are
Stab Therapeutics,
Aptatargets,
Nanobots Therapeutics,
Konexio Biotech,
Net-Pharma Hub,
Cellab - Cdmo,
Duponte Group,
Life Length,
A4cell,
Mimo Biosciences.
Thytech's categories are Biotechnology Research
Thytech's founding year is 2022
